American Journal of Epidemiology Vol. 173, No.

3
The Author 2010. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of DOI: 10.1093/aje/kwq358
Public Health. All rights reserved. For permissions, please e-mail: [email protected]. Advance Access publication:
December 10, 2010

Original Contribution

Familial Tendency and Risk of Nasopharyngeal Carcinoma in Taiwan: Effects of

Covariates on Risk

Wan-Lun Hsu, Kelly J. Yu, Yin-Chu Chien, Chun-Ju Chiang, Yu-Juen Cheng, Jen-Yang Chen,
Mei-Ying Liu, Sheng-Ping Chou, San-Lin You, Mow-Ming Hsu, Pei-Jen Lou, Cheng-Ping Wang,
Ji-Hong Hong, Yi-Shing Leu, Ming-Hsui Tsai, Mao-Chang Su, Sen-Tien Tsai, Wen-Yuan Chao,

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

Luo-Ping Ger, Peir-Rong Chen, Czau-Siung Yang, Allan Hildesheim, Scott R. Diehl, and
Chien-Jen Chen*
* Correspondence to Dr. Chien-Jen Chen, Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang,
Taipei 115, Taiwan (e-mail: [email protected]).

Initially submitted March 24, 2010; accepted for publication September 27, 2010.

In the present study, the authors compared the long-term risk of nasopharyngeal carcinoma (NPC) of male
participants in an NPC multiplex family cohort with that of controls in a community cohort in Taiwan after adjustment
for anti-Epstein-Barr virus (EBV) seromarkers and cigarette smoking. A total of 43 incident NPC cases were
identied from the 1,019 males in the NPC multiplex family cohort and the 9,622 males in the community cohort,
for a total of 8,061 person-years and 185,587 person-years, respectively. The adjusted hazard ratio was 6.8 (95%
condence interval (CI): 2.3, 20.1) for the multiplex family cohort compared with the community cohort. In the
evaluation of anti-EBV viral capsid antigen immunoglobulin A and anti-EBV deoxyribonuclease, the adjusted
hazard ratios were 2.8 (95% CI: 1.3, 6.0) and 15.1 (95% CI: 4.2, 54.1) for those positive for 1 EBV seromarker
and positive for both seromarkers, respectively, compared with those negative for both EBV seromarkers. The
adjusted hazard ratio was 31.0 (95% CI: 9.7, 98.7) for participants who reported a family history of NPC and who
were anti-EBV-seropositive compared with individuals without such a history who were anti-EBV-seronegative.
The ndings suggest that both family history of NPC and anti-EBV seropositivity are important determinants of
subsequent NPC risk and that the effect of family history on NPC risk cannot be fully explained by mediation
through EBV serologic responses.

carcinoma; cohort studies; herpesvirus 4, human

Abbreviations: CI, condence interval; DNase, deoxyribonuclease; EBV, Epstein-Barr virus; IgA, immunoglobulin A; NPC, naso-
pharyngeal carcinoma; VCA, viral capsid antigen.

Nasopharyngeal carcinoma (NPC) has a striking geo- age, salted fish consumption early in life, occupational ex-
graphic and ethnic distribution. In most parts of the world, posure to wood dust, long-term cigarette smoking, and a host
the incidence of NPC is less than 1 per 100,000 person- of genetic factors (3).
years; however, it occurs at relatively high rates in southern Studies of immigrant populations have shown that NPC
China and southeastern Asia (1). Epstein-Barr virus (EBV) incidence among the Chinese is higher than among African
is a well-documented etiologic agent for the development of Americans and Caucasians in the United States. NPC risk is
NPC. EBV is known to infect the vast majority of adults lower in second- and third-generation Chinese immigrants
worldwide (
95%), usually with lifelong persistence. How- to the United States than in first-generation immigrants, but
ever, only a small fraction of EBV-infected individuals de- the rates are still higher than those of other ethnic groups (4,
velop NPC in their lifetime (2). Various cofactors have been 5). These immigrant studies suggest that both genetic fac-
postulated to be important determinants of NPC, including tors and cultural lifestyle play a role in the etiology of NPC.

292 Am J Epidemiol 2011;173:292299

 Epstein-Barr Virus, Familial Tendency, and NPC 293

Familial aggregation of NPC has been widely docu- disease, and family history of NPC. Blood samples were
mented in both Chinese and low-risk populations (613). collected at the time of enrollment, immediately stored
Odds ratios for NPC ranging from 4 to 20 have been re- at 30
C, and later tested for antibody titers to 2 EBV
ported in case-control studies of individuals who reported antigens associated with NPC: anti-EBV viral capsid anti-
a first-degree family history of NPC compared with those gen (VCA) immunoglobulin A (IgA) and anti-EBV deoxy-
with no such history (1422). In a complex segregation ribonuclease (DNase). We tested for anti-EBV VCA IgA
analysis in China, Jia et al. (23) also reported that multiple through the use of indirect immunofluorescence assay
genetic and environmental factors likely contributed to the (30), and those participants with titers 1:10 were catego-
development of NPC. In a population-based cohort study in rized as positive. Anti-EBV DNase antibody levels were
Greenland and Denmark, the relative risk of NPC was 8.0 evaluated using an enzyme neutralization assay, and those
(95% confidence interval (CI): 1.1, 3.9) among 766 first- with a result of 2 units of DNase activity were deemed
degree relatives (24). Familial tendency for NPC may result positive. One unit of DNase activity is the amount of en-
from genetic and/or environmental risk factors shared by zyme required to convert 1 lg of double-strand DNA into
family members. acid-soluble material in 10 minutes at 37
C (31).
In our previous studies, both EBV seropositivity and Multiplex family cohort. As described previously, 475
long-term cigarette smoking were found to be associated multiplex families were identified from 20,450 NPC cases

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

with an increased NPC risk (2527). EBV seropositivity diagnosed between 1980 and 2003 (28, 32). A multiplex
was found to be more prevalent in family members of family was defined as one that had 2 NPC cases among
NPC cases (28). Seromarker measurements may reflect first-, second-, or third-degree adult relatives. Of these,
EBV infection itself, but they may also reflect an individ- a total of 358 multiplex families, including 2,240 unaffected
uals genetic ability to generate high levels of antibodies first-degree relatives (1,104 males and 1,136 females), were
against EBV or his/her susceptibility to EBV reactivation/ enrolled in the study between 1996 and 2004. There were 154
replication. Smoking behavior of an individual may be influ- first-degree relatives (84 males and 70 females) for whom
enced by parents and siblings (29). Although the results of incomplete national identification numbers prohibited link-
many studies have shown a tendency for familial aggrega- age to national registries and who were therefore excluded
tion of NPC, the authors of these studies did not examine from this analysis. In total, 75.9% of the diagnoses of NPC in
EBV status and cigarette smoking simultaneously. Our aim the 358 multiplex families were confirmed by cross-referenc-
was to evaluate the effect of family history on NPC risk and ing with the National Cancer Registry, the Death Certificate
determine how it might be mediated through other geneti- Registry, and the Chronic Major Disease Registry and/or ab-
cally driven or shared environmental risk factors, such as straction of medical charts. For NPC cases diagnosed after
EBV serology or cigarette smoking. To explore this issue, the implementation of the National Cancer Registry system in
we compared the relative risk of NPC among those with 2 1979, the confirmation rate was as high as 87.7%. Because we
affected family members with that of individuals lacking only recruited male subjects in the community cohort, we
such a family history, after accounting for serologic EBV excluded females from the multiplex cohort, giving us a total
patterns and cigarette smoking. of 1,020 male unaffected first-degree relatives. Informed con-
sent was obtained from study subjects. Institutional review
boards at both National Taiwan University and the National
MATERIALS AND METHODS Institutes of Health approved the study protocol and the in-
Cohort recruitment formed consent procedure.
All subjects were given a self-administered questionnaire
Community cohort. Details of the study have been pub- that assessed various risk factors, including socioeconomic
lished previously (26). Briefly, study subjects were recruited status, dietary intake, smoking exposure, occupational history,
between 1984 and 1986 from 6 townships in Taiwan. A total and alcohol consumption. Biologic samples, including saliva,
of 9,699 males who were 30 years of age participated in buccal (mouth) cells, and 35 mL of blood, were obtained for
our study. Seven were diagnosed with NPC before enroll- genotyping and EBV antibody testing. Samples were pro-
ment in the study, and an additional 67 reported a family cessed within 24 hours and then frozen at 80
C. Serum
history of NPC. These 74 individuals were excluded from samples obtained from the blood draw at the time of enroll-
this analysis. Each study participant provided written in- ment in our family study were tested for levels of antibodies to
formed consent for an interview, collection of a blood spec- VCA IgA and anti-DNase. EBV testing was performed by the
imen, and an otorhinolaryngologic examination and medical same testing laboratory using the same methods, with cutoff
consultation with physicians at the National Taiwan Univer- values identical to those used in the above-mentioned com-
sity Hospital. The institutional review board at National munity cohort study. For each batch of tests, 1 anti-EBV
Taiwan University approved the study protocol, and in- seronegative serum sample and 1 anti-EBV seropositive
formed consent was obtained. serum sample were used for quality control.
All participants were personally interviewed at local re-
search centers by well-trained research assistants who used Ascertainment of incident developed nasopharyngeal
a structured questionnaire. The information obtained from carcinoma
the questionnaire interview included sociodemographic
characteristics and information on cigarette smoking, alco- Newly diagnosed cases of NPC were ascertained using
hol drinking, diet, personal history of sinusitis or other nasal the national identification number by computerized linkage

Am J Epidemiol 2011;173:292299
294 Hsu et al.

Table 1. Characteristics of Participants in the Multiplex Family Statistical analysis

Cohort and Community Cohort Studies, Taiwan, 19842008
We used the Nelson-Aalen method to estimate the cumu-
Multiplex
Family
Community lative incidence of NPC among subjects with a family his-
Cohort P Value tory of NPC (multiplex family cohort members) and those
Cohort
No. % No. % without such a family history (community cohort members)
(33). The Mantel-Haenzel log-rank test was used to com-
Age at enrollment, years <0.001
pare cumulative incidence curves. The number of person-
<45 612 60.1 2,962 30.8 years of follow-up for each subject was calculated as the
4554 185 18.1 2,639 27.4 time between the date of enrollment and the date of diag-
55 222 21.8 4,021 41.8 nosis of NPC, the date of death, or the date of last link to
Ethnicitya <0.001 data from the National Cancer Registry (December 31,
2008), whichever came first. Incidence rates were calculated
Fukkinese 697 68.4 3,226 33.5
by dividing the number of incident cases of NPC by the
Hakka 249 24.4 6,395 66.5 number of person-years of follow-up. Coxs proportional
Other 73 7.2 0 0.0 hazards regression analyses were used to assess the univar-

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

Years of schoolingb <0.001 iate hazard ratio of developing NPC with a 95% confidence
06 188 18.4 6,383 67.8 interval. Adjusted hazard ratio estimates were also calcu-
7 831 81.6 3,036 32.2
lated after adjustment for various risk factors, including
age, ethnicity, years of schooling, anti-EBV seromarkers,
Cumulative cigarette <0.001
smoking, pack-yearsc cigarette smoking, and family history. The statistical signif-
icance for an interaction was tested through the comparison
0 412 40.5 3,316 35.7
of the likelihood of models with and without the inclusion of
<30 472 46.4 3,883 41.9 an interaction term. The results of anti-EBV VCA IgA and
30 134 13.1 2,074 22.4 anti-EBV DNase were missing for 53 and 54 individuals,
Anti-Epstein-Barr <0.001 respectively, including 1 NPC case from the community
virus viral cohort. The results of tests for anti-EBV VCA IgA levels
capsid antigen
immunoglobulin Ad determined by indirect immunofluorescent assay were miss-
Negative 572 75.7 9,460 98.9
ing for 263 multiplex family cohort members (including 3
NPC cases) (25.8%) because this particular test was discon-
Positive 184 24.3 109 1.1
tinued during the study and replaced by an enzyme-linked
Anti-Epstein-Barr virus 0.018 immunosorbent assay-based anti-EBV VCA IgA test. The
deoxyribonucleasee
results of anti-EBV DNase tests were missing for 16 indi-
Negative 908 90.5 8,420 88.0 viduals (1.6%) from the multiplex family cohort. Cumula-
Positive 95 9.5 1,148 12.0 tive exposure to cigarette smoke was defined in pack-years
Total 1,019 9,622 as the number of packs of cigarettes smoked per day mul-
a
tiplied by the number of years of cigarette smoking. Data
Data for ethnicity were not available for 1 participant in the com-
on cumulative cigarette smoking were not available for 1
munity cohort.
b
Data for years of schooling were not available for 203 participants
subject from the family cohort and 349 subjects from the
in the community cohort. community cohort, including 1 NPC case from the com-
c
Data for cumulative cigarette smoking were not available for 1 munity cohort. All statistical tests were 2-tailed.
participant in the multiplex family cohort and 349 participants in the
community cohort.
d RESULTS
Data for anti-Epstein-Barr virus viral capsid antigen immunoglob-
ulin A tested by using immunouorescence assay were not available
A total of 1,019 multiplex family cohort members and
for 263 participants in the multiplex family cohort and 53 participants in
the community cohort.
9,622 community cohort members were included in this
e
Data for anti-Epstein-Barr virus deoxyribonuclease were not analysis. Table 1 shows the distribution of baseline charac-
available for 16 participants in the multiplex family cohort and 54 teristics among participants in the 2 cohort studies according
participants in the community cohort. to age, ethnicity, years of schooling, cigarette smoking sta-
tus, and anti-EBV seromarkers. Individuals from the multi-
plex family cohort were younger and more likely to be
with the National Cancer Registry. Linkage was performed Fukkienese than were those from the community cohort.
for the period between the recruitment date and December Although most of the multiplex family cohort members
31, 2008. We identified a total of 36 and 11 newly diagnosed had 7 years of schooling, nearly 70% of the community
NPC cases from the community cohort and multiplex family cohort members had only 16 years of schooling. The prev-
cohort, respectively. Those subjects with NPC diagnosed alence of cigarette smoking was 59.5% in multiplex cohort
within a year of study enrollment were excluded (commu- family members and 64.3% in community cohort members.
nity cohort: n 3; multiplex family cohort: n 1) because Seropositivity to anti-EBV VCA IgA was observed among
those cases were much more likely to be preexisting NPC 24.3% of multiplex family cohort members, compared with
rather than incident cases. 1.1% of the community cohort members. The numbers of

Am J Epidemiol 2011;173:292299
 Epstein-Barr Virus, Familial Tendency, and NPC 295

A) those in the community cohort. Individuals with anti-EBV

0.015 seropositivity had a higher cumulative incidence of NPC
than did those with anti-EBV seronegativity. Smokers with
Cumulative Incidence

a cumulative cigarette-smoking exposure 30 pack-years

0.010 had a higher cumulative incidence of NPC than did those
with cigarette-smoking exposures <30 pack-years and
never smokers. The longer the follow-up duration, the
0.005 greater were the differences in cumulative NPC incidence.
Table 2 shows the incidence rates and adjusted hazard
ratios for developing NPC by family history, cumulative
0.00
pack-years of cigarette smoking, and anti-EBV sero-
0 5 10 15 20 25
markers. There were 33 incident NPC cases over a total of
Years of Follow-up
185,587.3 person-years of follow-up in the community co-
hort and 10 incident NPC cases over a total of 8,060.8
B) person-years of follow-up in the multiplex family cohort.
0.015
The mean durations of follow-up were 19.3 and 7.9 years

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

Cumulative Incidence

for the community cohort and the multiplex family cohort,

respectively. The incidence rates for NPC were 17.8 and
0.01
124.1 per 100,000 person-years in the community cohort
and the multiplex family cohort, respectively. The NPC in-
cidence in individuals who were seropositive for anti-EBV
0.005 VCA IgA and/or anti-EBV DNase was higher than that
observed in individuals seronegative for both anti-EBV
VCA IgA and anti-EBV DNase. Participants with 30
0.00 pack-years of cigarette smoking had a higher NPC incidence
0 5 10 15 20 25 than did those who smoked for <30 pack-years. Compared
Years of Follow-up with participants in the community cohort, participants in
C) the multiplex family cohort had an adjusted hazard ratio of
0.015 developing NPC of 11.7 (95% CI: 4.6, 29.9) after adjust-
ment for age, ethnicity, and years of schooling. After further
Cumulative Incidence

adjustment for anti-EBV seromarkers and cumulative pack-

0.01 years of cigarette smoking, the NPC risk remained signifi-
cantly higher for members of the multiplex family cohort
than for community cohort members (adjusted hazard
0.005 ratio 6.8, 95% CI: 2.3, 20.1). Compared with those in-
dividuals who were seronegative for anti-EBV VCA IgA,
those who were seropositive for anti-EBV VCA IgA had
0.00 a hazard ratio for 11.6 (95% CI: 4.7, 28.6) after adjustment
0 5 10 15 20 25
for age, ethnicity, and years of schooling. Compared with
those who were seronegative for anti-EBV DNase, those
Years of Follow-up
who were seropositive had a hazard ratio of 3.4 (95% CI:
1.7, 6.6) after adjustment of age, ethnicity, and years of
Figure 1. Cumulative incidence of nasopharyngeal carcinoma
during follow-up among 10,641 males in Taiwan by A) study cohort schooling. After further adjustment for family history and
(solid line: multiplex family cohort; dashed line: community cohort), cumulative cigarette smoking, the adjusted hazard ratio for
B) anti-Epstein-Barr virus seromarkers (solid line: seropositive for developing NPC was 2.8 (95% CI: 1.3, 6.0) for participants
anti-Epstein-Barr virus viral capsid antigen immunoglobulin A, anti who were seropositive for only 1 anti-EBV seromarker and
Epstein-Barr virus deoxyribonuclease, or both; dashed line: seroneg-
ative for both seromarkers), and C) cumulative pack-years of cigarette
15.1 (95% CI: 4.2, 54.1) for those who were seropositive for
smoking (solid line: cumulative cigarette smoking 30 pack-years; both anti-EBV seromarkers compared with participants who
dashed line: cumulative cigarette smoking <30 pack-years; dotted were seronegative for both anti-EBV seromarkers. Although
line: never smokers). Log-rank test statistics were 37.80 (P < a residual increase in risk was observed for cumulative
0.001), 23.49 (P < 0.001), and 5.71 (P 0.0576) for A, B, and C, pack-years of cigarette smoking after adjustment for family
respectively.
history and anti-EBV seromarkers, the effect was not statis-
tically significant (P 0.16).
The association with NPC for the combination of family
individuals who were seropositive for anti-EBV DNase was history, anti-EBV seromarkers, and cumulative pack-years
similar between the 2 cohorts. of cigarette smoking after adjustment for age, ethnicity, and
The cumulative incidence of NPC is shown in Figure 1 by years of schooling was further evaluated. As shown in
study cohort (A), anti-EBV seromarkers (B), and cumula- Table 3, no evidence for departure from a multiplicative
tive cigarette smoking (C). Members of the multiplex family model was observed for any of the joint effects evaluated.
cohort had a higher cumulative incidence of NPC than did Of interest is the fact that individuals with a family history

Am J Epidemiol 2011;173:292299
296 Hsu et al.

Table 2. Incidence of and Adjusted Hazard Ratios, for Nasopharyngeal Carcinoma, by Family History, Anti-Epstein-Barr Virus Seromarker
Status, and Cigarette Smoking at Study Entry, Taiwan, 19842008

No. of
95% 95%
No. of Person- Nasopharyngeal Cumulative Adjusted Adjusted
Variable Condence Condence
Participants Years Carcinoma Incidencea Hazard Ratiob Hazard Ratioc
Interval Interval
Cases

Family history
Community cohort 9,622 1,85,587.3 33 17.8 1.0 Referent 1.0 Referent
Multiplex family cohort 1,019 8,060.8 10 124.1 11.7 4.6, 29.9 6.8 2.3, 20.1
Anti-EBV VCA IgAd
Negative 10,032 1,87,921.4 32 17.0 1.0 Referent
Positive 293 3,395.2 7 206.2 11.6 4.7, 28.6
Anti-EBV
deoxyribonucleasee
Negative 9,328 1,70,610.8 30 17.6 1.0 Referent

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

Positive 1,243 21,836.7 12 55.0 3.4 1.7, 6.6
Combination of VCA
IgA and
deoxyribonucleasef
Both negative 8,880 1,67,090.5 24 14.4 1.0 Referent 1.0 Referent
Either one positive 1,373 23,248.6 12 51.6 3.5 1.7, 7.1 2.8 1.3, 6.0
Both positive 70 938.6 3 319.6 23.4 6.9, 79.1 15.1 4.2, 54.1
Cumulative cigarette
smoking, pack-yearsg
0 3,728 69,212.0 13 18.8 1.0 Referent 1.0 Referent
<30 4,355 82,033.8 14 17.1
30 2,208 36,085.3 14 38.8 2.3 1.1, 5.0 1.8 0.8, 4.1

Abbreviations: EBV, Epstein-Barr virus; IgA, immunoglobulin A; VCA, viral capsid antigen.
a
Per 100,000 person-years.
b
Adjusted for age (continuous), ethnicity (Fukkinese or non-Fukkinese), and years of schooling (06 years or 7 years).
c
Model included age (continuous), ethnicity (Fukkinese or non-Fukkinese), years of schooling (06 years or 7 years), family history, cumu-
lative cigarette smoking, and combination of anti-EBV VCA IgA tested by immunouorescence assay and anti-EBV deoxyribonuclease.
d
Data for anti-EBV VCA IgA tests were not available for 316 participants, including 4 nasopharyngeal carcinoma cases.
e
Data for anti-EBV deoxyribonuclease tests were not available for 70 participants, including 1 nasopharyngeal carcinoma case.
f
Data for the combination of VCA IgA and deoxyribonuclease were not available for 318 participants, including 4 nasopharyngeal carcinoma
cases.
g
Data for cumulative cigarette smoking were not available for 350 participants, including 2 nasopharyngeal carcinoma cases.

of NPC who were also seropositive for anti-EBV sero- There are some considerations to our study. First, the 2
markers had an adjusted hazard ratio of 31.0 (95% CI: cohorts were recruited at different times (1980s versus the
9.7, 98.7) compared with individuals with no family history late 1990s). NPC diagnostic methods may have changed
of NPC who were anti-EBV seronegative. over time. However, the overall incidence of NPC in Taiwan
was stable in the 1980s and 1990s (34). Second, individuals
DISCUSSION from the multiplex family cohort might have been more
concerned with health than those from the community
To our knowledge, this is the first prospective study to cohort. However, because persons with NPC are unlikely
evaluate the association between family history and NPC to remain symptom-free and because Taiwan has a national
risk after accounting for anti-EBV seromarkers and ciga- health care system with broad access, it is expected that
rette smoking. The study utilized data from 2 cohort studies nearly all NPC cases would ultimately be identified and
comprising over 10,000 individuals. The longitudinal design reported to the National Cancer Registry. Third, there were
minimized recall bias concerns related to the ascertainment some differences in the collection of data through structured
of NPC family history and exposure to environmental risk questionnaires, the temperatures for biospecimen storage,
factors. We also avoided issue of causal temporality by as- and the response rates between 2 study cohorts. The ques-
sessing EBV serostatus at study entry, which meant that tionnaire information was collected by personal interview
measurements occurred on average 10.2 years before diag- for the community cohort and by self-administration for
nosis in cases. Subjects were identified via linkage to a long- the multiplex family cohort. Although the collection
standing population-based national tumor registry. methods differed, the questions about sociodemographic

Am J Epidemiol 2011;173:292299
 Epstein-Barr Virus, Familial Tendency, and NPC 297

Table 3. Incidence of and Adjusted Hazard Ratios for Nasopharyngeal Carcinoma, by Combination of Anti-Epstein-Barr Virus Seromarkers,
Family History, and Cumulative Cigarette Smoking at Study Entry, Taiwan, 19842008

No. of Person- No. of Cumulative Hazard 95% Condence P for

Variable
Participants Years Cases Incidencea Ratiob Interval Interaction

Combination of VCA IgA and Family historyc 0.533

deoxyribonuclease
Both negative No 8,357 1,62,372.5 22 13.5 1.0 Referent
Both negative Yes 523 4,718.0 2 42.4 5.5 1.1, 26.8
Any positive No 1,210 22,104.7 10 45.2 3.1 1.4, 6.9
Any positive Yes 233 2,082.5 5 240.1 31.0 9.7, 98.7
Cumulative cigarette Family historyd 0.310
smoking,
pack-years
<30 No 7,199 1,44,173.4 18 12.5 1.0 Referent
<30 Yes 884 7,072.4 9 127.3 14.5 5.1, 41.2

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

30 No 2,074 35,101.5 13 37.0 2.7 1.2, 6.0
30 Yes 134 983.8 1 101.6 12.4 1.5, 102.8
Combination of VCA IgA and Cumulative cigarette 0.862
deoxyribonuclease smoking,
pack-yearse
Both negative <30 6,777 1,31,514.3 16 12.2 1.0 Referent
Both negative 30 1,810 30,268.1 7 23.1 1.9 0.7, 5.1
Any positive <30 1,038 17,771.0 9 50.6 4.2 1.9, 9.6
Any positive 30 352 5,474.3 5 91.3 6.9 2.1, 21.9

Abbreviations: IgA, immunoglobulin A; VCA, viral capsid antigen.

a
Per 100,000 person-years.
b
Adjusted for age (continuous), ethnicity (Fukkinese or non-Fukkinese), and years of schooling (06 years or 7 years).
c
Data for the combination of anti-Epstein-Barr virus seromarkers and family history were not available for 318 participants, including 4
nasopharyngeal carcinoma cases.
d
Data for the combination of cumulative cigarette smoking and family history were not available for 350 participants, including 2 nasopharyngeal
carcinoma cases.
e
Data for the combination of anti-Epstein-Barr virus seromarkers and cumulative cigarette smoking were not available for 664 participants,
including 6 nasopharyngeal carcinoma case.

characteristics and cigarette smoking habits were simple is that anti-EBV VCA IgA results using the indirect immu-
and easy to answer. The storage temperatures for biopseci- nofluorescent assay test were available for only 75% of in-
mens collected from the community and multiplex family dividuals enrolled in the multiplex family cohort. It is
cohorts were 30
C and 80
C, respectively. However, reassuring to note, however, that participants with missing
researchers tested for anti-EBV seromarkers within 3 anti-EBV VCA IgA data were similar to those for whom
months of recruitment, and therefore the difference in stor- data were not missing with respect to all exposure variables
age temperatures would not have affected the test results of (age, ethnicity, educational level, smoking status, and anti-
anti-EBVs. Although the response rate in the multiplex fam- EBV DNase) evaluated in this analysis. Lastly, the anti-EBV
ily cohort was higher than in the community cohort, the seromarker tests were done in the same laboratory at differ-
cohorts were representative samples of multiplex families ent times.
and community residents, respectively. Furthermore, the as- The magnitude of risk associated with a family his-
certainment of newly developed NPC through data linkage tory of NPC in our study was higher than that reported
with the National Cancer Registry was exactly the same for in most previous studies (adjusted hazard ratio 11.7)
both cohorts. (1422, 24). The most likely explanation for this differ-
Limitations of our study included the small number of ence is our requirement that members of our family
newly developed NPC cases resulting from the low inci- cohort report at least 2 family members affected with
dence of NPC. However, despite this limitation, we were NPC (i.e., multiplex families). In contrast, other studies
able to observe a statistically significant association be- considered individuals with 1 relatives affected with
tween family history of NPC and NPC risk, which was NPC. Our findings are therefore generalizable only to
consistent with findings from previous studies (1422, 24). individuals who report at least 2 family members with
Although it was interesting to evaluate the joint effects of NPC. In this group, our results suggest that unaffected
family history and anti-EBV seromarkers, it was difficult to individuals from NPC multiplex families with putatively
draw any definitive conclusions because of the small num- higher genetic risk might be at greatly elevated risk of
bers of NPC cases. Another potential limitation of our study NPC.

Am J Epidemiol 2011;173:292299
298 Hsu et al.

In our study, the hazard ratio for family history declined Taiwan University College of Medicine, Taipei, Taiwan
from 11.7 to 6.8 after adjustment for EBV seromarkers and (Mow-Ming Hsu, Pei-Jen Lou, Cheng-Ping Wang); Institute
cigarette smoking. The hazard ratio for seropositivity to of Biomedical Engineering, College of Medicine and Col-
anti-EBV VCA IgA and anti-EBV DNase also declined lege of Engineering, National Taiwan University, Taipei,
from 23.4 to 15.1 after adjustment for family history and Taiwan (Cheng-Ping Wang); Department of Radiation On-
cigarette smoking. In both instances, however, significant cology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
residual effects were noted after adjustment. In contrast, (Ji-Hong Hong); Department of Otolaryngology, MacKay
the effect of cigarette smoking was no longer significant Memorial Hospital, Taipei, Taiwan (Yi-Shing Leu); Depart-
after we controlled for family history and EBV seropositiv- ment of Otolaryngology, China Medical University Hospi-
ity. The effect of family history might theoretically be me- tal, Taichung, Taiwan (Ming-Hsui Tsai); Department of
diated through common genetic and/or environmental Otorhinolaryngology-Head and Neck Surgery, Chung Shan
factors shared by family members, such as EBV seroreac- Medical University Hospital, Taichung, Taiwan (Mao-Chang
tivity and cigarette smoking. The fact that family history of Su); Department of Speech Language Pathology and Audi-
NPC remained a significant risk factor after we controlled ology, Chung Shan Medical University Hospital, Taichung,
for these factors, however, suggests that familial aggrega- Taiwan (Mao-Chang Su); School of Medicine, Chung Shan
tion in cigarette smoking behavior and in EBV exposure Medical University Hospital, Taichung, Taiwan (Mao-Chang

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

and/or antibody responses were unlikely to fully explain Su); Department of Otolaryngology, National Cheng Kung
why individuals with a family history of NPC were at an University Hospital, Tainan, Taiwan (Sen-Tien Tsai,
increased risk of developing NPC themselves. In fact, based Wen-Yuan Chao); Department of Education and Research,
on our data, we estimated that approximately 28% of the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
risk of NPC associated with family history could be ex- (Luo-Ping Ger); Department of Otolaryngology, Buddhist
plained by EBV (35). It should be noted that in our study, Tzu-Chi General Hospital, Hualien, Taiwan (Peir-Rong
we did not directly measure the level of EBV exposure. Chen); and Center for Pharmacogenomics and Complex Dis-
Rather, serologic responses to EBV, as determined by anti- ease Research, New Jersey Dental, Newark, New Jersey
body levels detected in circulation, were used as a proxy for (Scott R. Diehl).
the degree of EBV exposure. To the extent that antibody This study was supported by the Department of Health,
production has an underlying host (e.g., genetic susceptibil- Executive Yuan, Taipei, Taiwan (grants DOH 75-0203-18
ity) and exogenous determinants (e.g., degree of EBV expo- and DOH 76-0203-17), the National Science Council, Tai-
sure determined by frequency of reactivation of latent EBV pei, Taiwan (grant NSC 95-2314-B-002-178), and intramu-
infections), our study was not capable of differentiating ral funds from the National Institutes of Health, United
between these different components. States.
To our knowledge, we are the first to evaluate the joint These data were presented in part at the 81st Taiwan
effect of family history of NPC, anti-EBV seromarkers, and Otolaryngological Society Conference, Taipei, Taiwan,
cigarette smoking on NPC risk in a prospective manner. We November 45, 2006.
found that both NPC family history and anti-EBV seropos- Conflict of interest: none declared.
itivity were important determinants of subsequent NPC risk
and that the effect of family history on NPC could not
be fully explained by mediation through EBV serologic
responses. REFERENCES
1. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in
Five Continents. Vol VIII. (IARC scientific publication no
155). Lyon, France: IARC Press; 2002.
ACKNOWLEDGMENTS 2. International Agency for Research on Cancer. Epstein-Barr
Virus and Kaposis Sarcoma Herpesvirus/Human Herpesvirus
Author affiliations: Genomics Research Center, Acade- 8. (IARC Monographs on the Evaluation of Carcinogenic
mia Sinica, Taipei, Taiwan (Wan-Lun Hsu, Yin-Chu Chien, Risks to Humans vol 70). Lyon, France: IARC Press; 1997.
San-Lin You, Chien-Jen Chen); Graduate Institute of 3. Chien YC, Chen CJ. Epidemiology and etiology of nasopha-
Epidemiology, College of Public Health, National Taiwan ryngeal carcinoma: gene-environment interaction. Cancer Rev
University, Taipei, Taiwan (Wan-Lun Hsu, Chun-Ju Chiang, Asia Pac. 2003;1(1):119.
Yu-Juen Cheng, Chien-Jen Chen); Division of Cancer 4. Chen CJ, You SL, Lin LH, et al. Cancer epidemiology and
Epidemiology and Genetics, National Cancer Institute, control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;
Bethesda, Maryland (Kelly J. Yu, Allan Hildesheim); 32(suppl):S66S81.
National Institute of Cancer Research, National Health 5. Sun LM, Epplein M, Li CI, et al. Trends in the incidence rates
of nasopharyngeal carcinoma among Chinese Americans living
Research Institutes, Chunan, Taiwan (Jen-Yang Chen,
in Los Angeles County and the San Francisco metropolitan
Sheng-Ping Chou); Graduate Institute of Microbiology, area, 19922002. Am J Epidemiol. 2005;162(12):11741178.
College of Medicine, National Taiwan University, Taipei, 6. Gajwani BW, Devereaux JM, Beg JA. Familial clustering of
Taiwan (Jen-Yang Chen, Czau-Siung Yang); Center of nasopharyngeal carcinoma. Cancer. 1980;46(10):23252327.
General Education, National Taipei College of Nursing, 7. Ko JY, Sheen TS, Hsu MM, et al. Familial clustering of na-
Taipei, Taiwan (Mei-Ying Liu); Department of Otolaryngol- sopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1998;
ogy, National Taiwan University Hospital and National 118(5):736737.

Am J Epidemiol 2011;173:292299
 Epstein-Barr Virus, Familial Tendency, and NPC 299

8. Zhang F, Zhang J. Clinical hereditary characteristics in naso- 23. Jia WH, Collins A, Zeng YX, et al. Complex segregation
pharyngeal carcinoma through Ye-Liangs family cluster. Chin analysis of nasopharyngeal carcinoma in Guangdong, China:
Med J (Engl). 1999;112(2):185187. evidence for a multifactorial mode of inheritance (complex
9. Loh KS, Goh BC, Lu J, et al. Familial nasopharyngeal carci- segregation analysis of NPC in China). Eur J Hum Genet.
noma in a cohort of 200 patients. Arch Otolaryngol Head Neck 2005;13(2):248252.
Surg. 2006;132(1):8285. 24. Friborg J, Wohlfahrt J, Koch A, et al. Cancer susceptibility in
10. Albeck H, Bentzen J, Ockelmann HH, et al. Familial clusters nasopharyngeal carcinoma familiesa population-based co-
of nasopharyngeal carcinoma and salivary gland carcinomas in hort study. Cancer Res. 2005;65(18):85678572.
Greenland natives. Cancer. 1993;72(1):196200. 25. Cheng YJ, Hildesheim A, Hsu MM, et al. Cigarette smoking,
11. Levine PH, Pocinki AG, Madigan P, et al. Familial nasopha- alcohol consumption and risk of nasopharyngeal carcinoma in
ryngeal carcinoma in patients who are not Chinese. Cancer. Taiwan. Cancer Causes Control. 1999;10(3):201207.
1992;70(5):10241029. 26. Chien YC, Chen JY, Liu MY, et al. Serologic markers of
12. Coffin CM, Rich SS, Dehner LP. Familial aggregation of na- Epstein-Barr virus infection and nasopharyngeal
sopharyngeal carcinoma and other malignancies. A clinico- carcinoma in Taiwanese men. N Engl J Med. 2001;345(26):
pathologic description. Cancer. 1991;68(6):13231328. 18771882.
13. Olajos J, Fule E, Erfan J, et al. Familial clustering of naso- 27. Hsu WL, Chen JY, Chien YC, et al. Independent effect of EBV
pharyngeal carcinoma in a non-endemic geographical region. and cigarette smoking on nasopharyngeal carcinoma: a 20-

Downloaded from http://aje.oxfordjournals.org/ at UNIVERSITY OF ARIZONA on June 2, 2015

Report of two Hungarian cases and a review of the literature. year follow-up study on 9,622 males without family history in
Acta Otolaryngol. 2005;125(9):10081013. Taiwan. Cancer Epidemiol Biomarkers Prev. 2009;18(4):
14. Chen DL, Huang TB. A case-control study of risk factors of 12181226.
nasopharyngeal carcinoma. Cancer Lett. 1997;117(1):1722. 28. Pickard A, Chen CJ, Diehl SR, et al. Epstein-Barr virus se-
15. Yu MC, Ho JH, Lai SH, et al. Cantonese-style salted fish as roreactivity among unaffected individuals within high-risk
a cause of nasopharyngeal carcinoma: report of a case-control nasopharyngeal carcinoma families in Taiwan. Int J Cancer.
study in Hong Kong. Cancer Res. 1986;46(2):956961. 2004;111(1):117123.
16. Chen CJ, Liang KY, Chang YS, et al. Multiple risk factors of 29. Avenevoli S, Merikangas KR. Familial influences on adoles-
nasopharyngeal carcinoma: Epstein-Barr virus, malarial in- cent smoking. Addiction. 2003;98(suppl 1):120.
fection, cigarette smoking and familial tendency. Anticancer 30. Henle G, Henle W. Epstein-Barr virus-specific IgA serum
Res. 1990;10(2B):547553. antibodies as an outstanding feature of nasopharyngeal carci-
17. Sriamporn S, Vatanasapt V, Pisani P, et al. Environmental risk noma. Int J Cancer. 1976;17(1):17.
factors for nasopharyngeal carcinoma: a case-control study in 31. Chen JY, Chen CJ, Liu MY, et al. Antibody to Epstein-Barr
northeastern Thailand. Cancer Epidemiol Biomarkers Prev. virus-specific DNase as a marker for field survey of patients
1992;1(5):345348. with nasopharyngeal carcinoma in Taiwan. J Med Virol.
18. Yu MC, Garabrant DH, Huang TB, et al. Occupational and 1989;27(4):269273.
other non-dietary risk factors for nasopharyngeal carcinoma in 32. Yang XR, Diehl S, Pfeiffer R, et al. Evaluation of risk factors
Guangzhou, China. Int J Cancer. 1990;45(6):10331039. for nasopharyngeal carcinoma in high-risk nasopharyngeal
19. Yuan JM, Wang XL, Xiang YB, et al. Non-dietary risk factors carcinoma families in Taiwan. Cancer Epidemiol Biomarkers
for nasopharyngeal carcinoma in Shanghai, China. Int J Prev. 2005;14(4):900905.
Cancer. 2000;85(3):364369. 33. Breslow N, Crowley J. A large sample study of the life table
20. Henderson BE, Louie E, SooHoo Jing J, et al. Risk factors and product limit estimates under random censorship. Ann
associated with nasopharyngeal carcinoma. N Engl J Med. Stat. 1974;2(3):437453.
1976;295(20):11011106. 34. Hsu C, Shen YC, Cheng CC, et al. Difference in the incidence
21. Yan L, Xi Z, Drettner B. Epidemiological studies of naso- trend of nasopharyngeal and oropharyngeal carcinomas in
pharyngeal cancer in the Guangzhou area, China. Preliminary Taiwan: implication from age-period-cohort analysis. Cancer
report. Acta Otolaryngol. 1989;107(5-6):424427. Epidemiol Biomarkers Prev. 2006;15(5):856861.
22. Ung A, Chen CJ, Levine PH, et al. Familial and sporadic cases 35. Freedman LS, Graubard BI, Schatzkin A. Statistical validation
of nasopharyngeal carcinoma in Taiwan. Anticancer Res. of intermediate endpoints for chronic diseases. Stat Med.
1999;19(1B):661665. 1992;11(2):167178.

Am J Epidemiol 2011;173:292299